Global Non-Invasive Monitoring Device Market: Information by Type (Cardiac Monitoring Devices, Brain Monitoring Devices, Blood Pressure Monitoring Devices, Anesthesia Monitoring Devices and Blood Glucose Monitoring Devices), Modality (Table-Top Devices and Wearable Devices), Application (Cardiology, Neurology and Oncology), End User (Hospitals & Clinics, Diagnostic Centers, Research & Academic Institutes and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) – Forecast till 2023
GET FREE SAMPLE COPY TODAY FOR FUTURE ADVANCEMENT
https://www.marketresearchfuture.com/sample_request/1506
Major Companies in Non-Invasive Monitoring Device Market Analyzed are:
General Electric Company (US), Medtronic PLC (Ireland), KONINKLIJKE PHILIPS NV (Netherlands), Abbott (US), Omron Corporation (Japan), Vaso Corporation (US), Integrity Applications (Israel), CAS Medical Systems, Inc. (US), A&D Medical Inc. (Japan), Tensys Medical Inc (US), OrSense Ltd (Israel), CNSystems Medizintechnik AG (Austria), NIMedical (Israel) and Advanced Brain Monitoring, Inc (US).
Non-Invasive Monitoring Device Market Highlights
Non-invasive monitoring devices enable measurement of vital signs of the patient without the need of insertion in the body. Non-invasive monitoring devices are witnessing a rage and top the list of clinicianswish list.The global non-invasive monitoring device market is experiencing a demand cliff and the market is expected to undergo frenzy.
According to Market Research Future (MRFR), the global non-invasive monitoring device market is expected to garner a valuation of USD 21,586.2 MN by the end of 2023. In its recently published analysis, MRFR also asserts that the market would register a CAGR of over 6.8% over the assessment period (2016-2023).
Global Non-Invasive Monitoring Device Market – Segments
The report is segmented into four dynamics to widen the scope of understanding,
By Type: Cardiac Monitoring Devices (Electrocardiography and Cardiac Output Monitors), Brain Monitoring Devices, Blood Pressure Monitoring Devices, Anesthesia Monitoring Devices, And Blood Glucose Monitoring Devices, among others.
By Modality: Table-Top Devices and Wearable Devices, among others.
By End Users: Hospital & Clinics, Diagnostic Centers, and Research & Academic Institutes, among others.
By Regions: North America, Europe, Asia Pacific, and the Rest-of-the-World.
TABLE OF CONTENTS:
CHAPTER 4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing Prevalence Of Cardiovascular Diseases
4.2.2 Increasing Adoption Of Non-Invasive Technology
4.2.3 Increasing Prevalence Of Neurovascular Diseases
4.2.4 Increasing Geriatric Population
4.2.5 Favorable Reimbursement Policies
4.3 Restraints
4.3.1 Erroneous Readings
4.3.2 Stringent Regulatory Norms
4.4 Opportunities
4.4.1 Development Of Non-Invasive Monitoring Devices To Measure The Blood Glucose Level 38
4.4.2 Partnership Between Big Companies And Their Geographic Expansion Is Becoming An Entrance Gateway For Budding Companies
4.5 Macroeconomic Indicator
4.6 Technology Trend & Assessment
4.6.1 Optical Techniques
4.6.2 Transdermal Techniques
4.6.3 Electrochemical Techniques
Continued…
LIST OF TABLES:
TABLE 1 PRIMARY INTERVIEWS
TABLE 2 GLOBAL NON-INVASIVE MONITORING DEVICE MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 3 GLOBAL NON-INVASIVE CARDIAC MONITORING DEVICE MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 4 GLOBAL NON-INVASIVE CARDIAC MONITORING DEVICE MARKET BY REGION, 2014 TO 2023 (USD MILLION)
TABLE 5 GLOBAL NON-INVASIVE ELECTROCARDIOGRAPH MONITORING DEVICE MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
Continued…
Browse More Information On This Report at @https://www.marketresearchfuture.com/reports/non-invasive-monitoring-device-market-1506
Industry/ Innovation/ Related News:
12 Jun 2019 —- Nemaura Medical received European approval for the first non-invasive continuous glucose monitor branded SugarBEAT. SugarBEAT owing to its convenience satisfies the unmet need of painless non-invasive glucose testing. Sugar BEAT can be connected to Bluetooth-enabled smartphone. SugarBEAT is a disposable adhesive patch possessing a rechargeable sensor which continuouslymeasures glucose readingsevery 5 minutes. SugarBEAT enables real-time glucose profile and analysis of data to detect patterns. Nemaura Medical is expected to launch SugarBEAT in Europe in last quarter of 2019.
Related news
Bariatric Surgery Devices– Market Research Report – Forecast to 2023
Capillary Blood Collection Devices– Market Research Report – Global Forecast till 2023
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with the technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Email:
sales@marketresearchfuture.com
